Monocyte-induced development of Th17 cells and the release of S100 proteins are involved in the pathogenesis of graft-versus-host disease

Journal of Immunology

Volumn 193, Issue 7, 2014, Pages 3355-3365

  Reinhardt, Katharina ^a   Foell, Dirk ^b   Vogl, Thomas ^b   Mezger, Markus ^a   Wittkowski, Helmut ^b   Fend, Falko ^a   Federmann, Birgit ^a   Gille, Christian ^a   Feuchtinger, Tobias ^a   Lang, Peter ^a   Handgretinger, Rupert ^a   Bethge, Wolfgang Andreas ^a   Holzer, Ursula ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN S 100; PROTEIN S100A12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CELL ACTIVATION; CELL CONTACT; CELLULAR IMMUNITY; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; FECES ANALYSIS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MONOCYTE; PHAGOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; TH17 CELL; UPREGULATION; ACUTE DISEASE; ADOLESCENT; BLOOD; CELL CULTURE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; FOLLOW UP; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; PRESCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; INFLAMMATION; MALE; MONOCYTES; S100 PROTEINS; TH17 CELLS;

EID: 84907218304     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400983     Document Type: Article

References (55)

1. Sui, W., X. Hou, W. Che, J. Chen, M. Ou, W. Xue, and Y. Dai. 2013. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus. Clin. Immunol. 148: 186-197.
2. Gyurkocza, B., A. Rezvani, and R. F. Storb. 2010. Allogeneic hematopoietic cell transplantation: the state of the art. Expert Rev. Hematol. 3: 285-299.
3. Paczesny, S., S. W. Choi, and J. L. Ferrara. 2009. Acute graft-versus-host disease: new treatment strategies. Curr. Opin. Hematol. 16: 427-436.
4. Broady, R., J. Yu, V. Chow, A. Tantiworawit, C. Kang, K. Berg, M. Martinka, M. Ghoreishi, J. Dutz, and M. K. Levings. 2010. Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood 116: 5748-5751.
5. Carayol, G., J. H. Bourhis, M. Guillard, J. Bosq, C. Pailler, L. Castagna, J. P. Vernant, J. L. Pico, M. Hayat, S. Chouaib, and A. Caignard. 1997. Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease. Transplantation 63: 1307-1313.
6. Murphy, W. J., L. A. Welniak, D. D. Taub, R. H. Wiltrout, P. A. Taylor, D. A. Vallera, M. Kopf, H. Young, D. L. Longo, and B. R. Blazar. 1998. Differential effects of the absence of interferon-gamma and IL-4 in acute graftversus-hos t disease after allogeneic bone marrow transplantation in mice. J. Clin. Invest. 102: 1742-1748.
7. Yang, Y. G., B. R. Dey, J. J. Sergio, D. A. Pearson, and M. Sykes. 1998. Donorderived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin. J. Clin. Invest. 102: 2126-2135.
8. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-9 49.
9. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population tha t induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
10. Hoeve, M. A., N. D. Savage, T. de Boer, D. M. Langenberg, R. de Waal Malefyt, T. H. Ottenhoff, and F. A. Verreck. 2006. Di vergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur. J. Immunol. 36: 661-670.
11. Wilson, N. J., K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Matts on, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8: 950-957.
12. Evans, H. G. , T. Suddason, I. Jackson, L. S. Taams, and G. M. Lord. 2007. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. USA 104: 17034-17039.
13. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
14. Mathur, A. N., H. C. Chang, D. G. Zisoulis, G. L. Stritesky, Q. Yu, J. T. O'Malley, R. Kapur, D. E. Levy, G. S. Kansas, and M. H. Kaplan. 2007. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 178: 4901-4907.
15. Coghill, J. M., S. Sarantopoulos, T. P. Moran, W. J. Murphy, B. R. Blazar, and J. S. Serody. 2011. Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood 117: 3268-3276.
16. Kolls, J. K., and S. A. K hader. 2010. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev. 21: 443-448.
17. Fulton, L. M., M. J. Carlson, J. M. Coghill, L. E. Ott, M. L. West, A. Panoskaltsis-Mortari, D. R. Littman, B. R. Blazar, and J. S. Serody. 2012. Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORgammat. J. Immunol. 189: 1765-1772.
18. Matusevicius, D., P. Kivisakk, B. He, N. Kostulas, V. Ozenci, S. Fredrikson, and H. Link. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5: 101-104.
19. Kotake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, et al. 1999. IL-17 in sy novial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103: 1345-1352.
20. Honorati, M. C., R. Meliconi, L. Pulsatelli, S. Canè, L. Frizziero, and A. Facchini. 2001. High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheu matology 40: 522-527.
21. Wong, C. K., C. Y. Ho, F. W. Ko, C. H. Chan, A. S. Ho, D. S. Hui, and C. W. Lam. 2001. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines ( IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin. Exp. Immunol. 125: 177-183.
22. Kurasawa, K., K. Hirose, H. Sano, H. Endo, H. Shinkai, Y. Nawata, K. Takabayashi, and I . Iwamoto. 2000. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 43: 2455-2463.
23. Nielsen, O. H., I. Kirman, N. Rüdiger, J. Hendel, and B. Vainer. 2003. Upregulation of interleukin-12 and-17 in active inflammatory bowel disease. Scand. J. Gastroenterol. 38: 180-185.
24. Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expressi on of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
25. Carlson, M. J., M. L. West, J. M. Coghill, A. Panoskaltsis-Mortari, B. R. Blazar, and J. S. Serody. 2009. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 113: 1365-1374.
26. Dander E.,A. Balduzzi,G. Zappa,G. Lucchini,P. Perseghin,V. Andrè, E. Todisco,D. Rahal,M. Migliavacca,D. Longoni,et al. 2009. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation. 88: 1261-1272.
27. Ferrara, J. L., and P. Reddy. 2006. Pathophysiology of graft-versus-host disease. Semin. Hematol. 43: 3-10.
28. Foell, D., and J. Roth. 2004. Proinf lammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 50: 3762-3771.
29. Foell, D., H. Wittkowski, Z. Ren, J. Turton, G. Pang, J. Daebritz, J. Ehrchen, J. Heidemann, T. Borody, J. Roth, and R. Clancy. 2008. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J. Pathol. 216: 183-192.
30. Roth, J., T. Vogl, C. Sorg, and C. Sunderkö tter. 2003. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24: 155-158.
31. Foell, D., H. Wi ttkowski, C. Kessel, A. Lüken, T. Weinhage, G. Varga, T. Vogl, T. Wirth, D. Viemann, P. Bjö rk, et al. 2013. Proinflammatory S100A12 can activate human monocytes via Toll-like receptor4. Am. J. Respir. Crit. Care Med. 187: 1324-1334.
32. Vogl, T., K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, M. A. van Zoelen, W. Nacken, D. Foell, T. van der Poll, C. Sorg, and J. Roth. 2007. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13: 1042-1049.
33. Kaiser, T., J. Langhorst, H. Wittkowski, K. Becker, A. W. Friedrich, A. Rueffer, G. J. Dobos, J. Roth, and D. Foell. 2007. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 56: 1706-1713.
34. Foel l, D., T. Kucharzik, M. Kraft, T. Vogl, C. Sorg, W. Domschke, and J. Roth. 2003. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52: 847-853.
35. Dä britz, J., J. Langhorst, A. Lügering, J. Heidemann, M. Mohr, H. Wittkowski, T. Krummenerl, and D. Foell. 2013. Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12. Inflamm. Bowel Dis. 19: 1130-1138.
36. Bacigalupo, A. 2004. Third EBMT/AMGEN Workshop on reduced -intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus. Bone Marrow Transplant. 33: 691-696.
37. Vogl, T., C. Prö pper, M. Hartmann, A. Strey, K. Strupat, C. van den Bos, C. Sorg, and J. Roth. 1999. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J. Biol. Chem. 274: 25291-25296.
38. van den Bos, C., A. Rammes, T. Vogl, R. Boynton, J. Zaia, C. Sorg, and J. Roth. 1998. Copurification of P6, MRP8, and MRP14 from human granulocytes and separation of individual proteins. Protein Expr. Purif. 13: 313-318.
39. Langhorst, J., S. Elsenbruch, T. Mueller, A. Rueffer, G. Spahn, A. Michalsen, and G. J. Dobos. 2005. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm. Bowel Dis. 11: 1085-1091.
40. de Jong, N. S., S. T. Leach, and A. S. Day. 2006. Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. Inflamm. Bowel Dis. 12: 566-572.
41. Frosch, M., A. Strey, T. Vogl, N. M. Wulffraat, W. Kuis, C. Sunderkötter, E. Harms, C. Sorg, and J. Roth. 2000. Myeloid-related proteins 8 and 14 are specifically secreted during i nteraction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 43: 628-637.
42. Foell, D., J. Her nández-Rodríguez, M. Sánchez, T. Vogl, M. C. Cid, and J. Roth. 2004. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J. Pathol. 204: 311-316.
43. Yamaoka, M., N. Maeda, S. Nakamura, T. Mori, K. Inoue, K. Matsuda, R. Sekimoto, S. Kashine, Y. Nakagawa, Y. Tsushima, et al. 2013. Gene expression levels of S100 protein family in blood cells are associated with insulin resistance and inflammation (peripheral blood S100 mRNAs and metabolic syndrome). Biochem. Biophys. Res. Commun. 433: 450-455.
44. Johnson, M. R., K. Wang, J. B. Smith, M. J. Heslin, and R. B. Diasio. 2000. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal. Biochem. 278: 175-184.
45. de Jager, W., E. P. Hop penreijs, N. M. Wulffraat, L. R. Wedderburn, W. Kuis, and B. J. Prakken. 2007. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann. Rheum. Dis. 66: 5 89-598.
46. Ferrara, J. L., J. E. Levine, P. Reddy, and E. Holler. 2009. Graft-versus-host disease. Lancet 373: 1550-1561.
47. Ferraccioli G.,A. Carbonella,E. Gremese,S. Alivernini. 2012. Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation. Discov. Med. 14: 379-388.
48. Woo, P., and L. R. Wedderburn. 199 8. Juvenile chronic arthritis. Lancet 351: 969-973.
49. Evans, H. G., N. J. Gullick, S. Kelly, C. Pitzalis, G. M. Lord, B. W. Kirkham, and L. S. Taams. 2009. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc. Natl. Acad. Sci. USA 106: 6232-6237.
50. Wittkowski, H., D. Foell, E. af Klint, L. De Rycke, F. De Keyser, M. Frosch, A. K. Ulfgren, and J. Roth. 2007. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis. Ann. Rheum. Dis. 66: 1020-1025.
51. Paczesny, S., D. Hanauer, Y. Sun, and P. Reddy. 2010. New perspectives on the biology of acute GVHD. Bone Marrow Transplant. 45: 1-11.
52. Chiusolo, P., E. Metafuni, S. Giammarco, S. Bellesi, N. Piccirillo, C. Fanali, M. Castagnola, C. Zuppi, T. De Michele, G. Leone, and S. Sica. 2012. Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation. Blood 120: 4443-4444.
53. Rodriguez-Otero, P., R. Porcher, R. Peffault de Latour, M. Contreras, Y. Bouhnik, A. Xhaard, A. Andreoli, P. Ribaud, N. Kapel, A. Janin, et al . 2012. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease. Blood 119: 5909-5917.
54. Batliwalla, F. M., E. C. Baechler, X. Xiao, W. Li, S. Balasubramanian, H. Khalili, A. Damle, W. A. Ortmann, A. Perrone, A. B. Kantor, et al. 2005. Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun. 6: 388-397.
55. Bovin, L. F., K. Rieneck, C. Workman, H. Nielsen, S. F. Sørensen, H. Skjødt, A. Florescu, S. Brunak, and K. Bendtzen. 2004. Blood cell gene expression profiling in rheumatoid a rthritis: discriminative genes and effect of rheumatoid factor. Immunol. Lett. 93: 217-226.